Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

<< Previous

Bullboard Posts

Next >>

Post by 666999on Apr 01, 2021 11:58am

149 Views

Post# 32923109

CEO

I was listening to ceo presentation, and can say that MYCO has al lot of potential, story is developing and going forward
In Q3-Q4 it will be much more clear about future and what was done by company
Biotech companies can have big spikes up and down, so predicting share price is not very cleaver
Share price is at support level as predicted by current market sentiment
Hold to your shares, but dont expect CAD 2 in a week
Hope Im wrong :)))
Cheers

<< Previous

Bullboard Posts

Next >>

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle